Order Article Reprints

Le Gall T, Berchel M, Davies L, Mottais A, Ghanem R, Fautrel A, Gill D, Hyde S, Lehn P, Lehn J-M, et al. Aerosol-Mediated Non-Viral Lung Gene Therapy: The Potential of Aminoglycoside-Based Cationic Liposomes. Pharmaceutics. 2022; 14(1):25. https://doi.org/10.3390/pharmaceutics14010025

Le Gall, Tony, Mathieu Berchel, Lee Davies, Angélique Mottais, Rosy Ghanem, Alain Fautrel, Deborah Gill, Steve Hyde, Pierre Lehn, Jean-Marie Lehn, and et al. 2022. "Aerosol-Mediated Non-Viral Lung Gene Therapy: The Potential of Aminoglycoside-Based Cationic Liposomes" Pharmaceutics 14, no. 1: 25. https://doi.org/10.3390/pharmaceutics14010025

Le Gall, T., Berchel, M., Davies, L., Mottais, A., Ghanem, R., Fautrel, A., Gill, D., Hyde, S., Lehn, P., Lehn, J.-M., Lemiègre, L., Benvegnu, T., Jaffrès, P.-A., Pitard, B., & Montier, T. (2022). Aerosol-Mediated Non-Viral Lung Gene Therapy: The Potential of Aminoglycoside-Based Cationic Liposomes. Pharmaceutics, 14(1), 25. https://doi.org/10.3390/pharmaceutics14010025